Viewing Study NCT02836795


Ignite Creation Date: 2025-12-24 @ 1:42 PM
Ignite Modification Date: 2026-03-30 @ 7:52 AM
Study NCT ID: NCT02836795
Status: COMPLETED
Last Update Posted: 2025-06-08
First Post: 2016-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module